Vertex is expanding beyond its cystic fibrosis franchise.
Private equity and corporate ownership are driving up prices and forcing people to make awful choices about their animal ...
Vertex Pharmaceuticals Incorporated (NASDAQ:VRTX) has spent years building a highly profitable cystic fibrosis franchise. Now ...
The trial also met both secondary endpoints; FDA accepted Vertex’s application for potential accelerated approval, with a Nov ...
A minireview reports that cardiomyocyte-specific loss of the Bmal1 clock gene increases cardiac growth hormone sensitivity in ...
We bring you insights about the biggest stories impacting the rare disease community and highlight the research being done that will change the way we think about modern medicine for everyone. CNBC ...
Researchers found that high clinical suspicion is needed for earlier diagnosis of AAV, including thorough symptom review and ...
A nationally-published, award-winning journalist, Alex Biese joined the CURE team as an assistant managing editor in April 2023. Prior to that, Alex's work was published in outlets including the ...
Vertex Pharmaceuticals (VRTX) has appointed Daniel Brennan, a former Boston Scientific chief financial officer, to its board ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results